SEC Company Response from AETHLON MEDICAL INC (AEMD) (CIK 0000882291) (AEMD) — Mar 26, 2020
AETHLON MEDICAL INC (AEMD) (CIK 0000882291)
Date: March 26, 2020 · CIK: 0000882291 · Accession: 0001683168-20-000961
AI Filing Summary & Sentiment
File numbers found in text: 333-237269
Show Raw Text
CORRESP
1
filename1.htm
Aethlon Medical, Inc.
9635 Granite Ridge Drive, Suite 100
San Diego, California 92123
March 26, 2020
Via
Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Irene Paik
Re:
Aethlon Medical, Inc. (the “Company”)
Registration Statement on Form S-3 (File No. 333-237269)
Acceleration Request
Requested Date:
March 30, 2020
Requested Time:
4:15 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”)
take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:15 P.M. Eastern
Time on March 30, 2020, or as soon thereafter as is practicable.
If you have any questions regarding this
request, please contact Julie Robinson of Cooley LLP at (858) 550-6092. Thank you for your assistance with this matter.
Very truly yours,
Aethlon
medical, Inc.
/s/ James B. Frakes
James B. Frakes
Chief Financial Officer